Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response
Byong-Su Jang, Hyeran Kim, Shinn-Won Lim, Ki-Won Jang, Doh-Kwan Kim
Psychiatry Investig. 2008;5(3):193-198.   Published online 2008 Sep 30     DOI: https://doi.org/10.4306/pi.2008.5.3.193
Circulating S100B levels at birth and risk of six major neuropsychiatric or neurological disorders: a two-sample Mendelian Randomization Study
Mengyu Pan, James M. Roe, Ron Nudel, Andrew J. Schork, Olena Iakunchykova, Anders M. Fjell, Kristine B. Walhovd, Thomas Werge, Chi-hua Chen, Michael E. Benros, Yunpeng Wang
Translational Psychiatry.2023;[Epub]     CrossRef
Increased Serum S100β Concentration is Associated with Depression in Parkinson’s Disease
Guanghui Jiang, Cuicui Sheng, Luxia Yan, Zipeng Wang, Qing Wang, Rui Chen, Ying Zhao
Neuropsychiatric Disease and Treatment.2023; Volume 19: 1865.     CrossRef
Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders
Lyudmila A. Levchuk, Olga V. Roschina, Ekaterina V. Mikhalitskaya, Elena V. Epimakhova, German G. Simutkin, Nikolay A. Bokhan, Svetlana A. Ivanova
Journal of Personalized Medicine.2023; 13(9): 1423.     CrossRef
Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review
Tomasz Kozlowski, Weronika Bargiel, Maksymilian Grabarczyk, Maria Skibinska
Brain Sciences.2023; 13(9): 1334.     CrossRef
Correlation between S100B and severity of depression in MDD: A meta-analysis
Umit Tural, Molly Kennedy Irvin, Dan Vlad Iosifescu
The World Journal of Biological Psychiatry.2022; 23(6): 456.     CrossRef
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
Ricard Navinés, Giovanni Oriolo, Igor Horrillo, Myriam Cavero, Bruno Aouizerate, Martin Schaefer, Lucile Capuron, J Javier Meana, Rocio Martin-Santos
International Journal of Neuropsychopharmacology.2022; 25(6): 468.     CrossRef
ProBDNF as an Indicator of Improvement among Women with Depressive Episodes
Weronika Zwolińska, Maria Skibinska, Agnieszka Słopień, Monika Dmitrzak-Węglarz
Metabolites.2022; 12(4): 358.     CrossRef
Serum S100B protein after electroconvulsive therapy in patients with depression
Krzysztof Gbyl, Niklas Rye Jørgensen, Poul Videbech
Acta Neuropsychiatrica.2022; 34(5): 269.     CrossRef
Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression
Federico E. Turkheimer, Noha Althubaity, Julia Schubert, Maria A. Nettis, Oliver Cousins, Danai Dima, Valeria Mondelli, Edward T. Bullmore, Carmine Pariante, Mattia Veronese
Brain, Behavior, and Immunity.2021; 91: 487.     CrossRef
Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis
Yachen Shi, Di Luan, Ruize Song, Zhijun Zhang
European Neuropsychopharmacology.2020; 41: 40.     CrossRef
Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress
Shirley Alteba, Tomer Mizrachi Zer-Aviv, Adi Tenenhaus, Gilad Ben David, Jacob Adelman, Cecilia J. Hillard, Ravid Doron, Irit Akirav
European Neuropsychopharmacology.2020; 39: 70.     CrossRef
Plasma Neuronal and Glial Markers and Anterior Cingulate Metabolite Levels in Major Depressive Disorder: A Pilot Study
Emrah Güleş, Dan Vlad Iosifescu, Ümit Tural
Neuropsychobiology.2020; 79(3): 214.     CrossRef
S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy
Angela Carlier, Kimberly Boers, Robert Veerhuis, Filip Bouckaert, Pascal Sienaert, Piet Eikelenboom, Mathieu Vandenbulcke, Max L. Stek, Eric van Exel, Annemiek Dols, Didi Rhebergen
Psychoneuroendocrinology.2019; 110: 104414.     CrossRef
Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
Manish K. Jha, Abu Minhajuddin, Bharathi S. Gadad, Cherise Chin Fatt, Madhukar H. Trivedi
Pharmaceuticals.2019; 12(4): 184.     CrossRef
Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia
Takashi Ishii, Kotaro Hattori, Tomoko Miyakawa, Kentaro Watanabe, Shinsuke Hidese, Daimei Sasayama, Miho Ota, Toshiya Teraishi, Hiroaki Hori, Sumiko Yoshida, Akihiko Nunomura, Kazuyuki Nakagome, Hiroshi Kunugi
Biochemical and Biophysical Research Communications.2018; 497(2): 683.     CrossRef
Does S100B have a potential role in affective disorders? A literature review
Hilda Kroksmark, Maj Vinberg
Nordic Journal of Psychiatry.2018; 72(7): 462.     CrossRef
Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B
Chun-Xiao Dai, Chang-Chun Hu, Yu-Shan Shang, Jian Xie
Medicine.2018; 97(39): e12421.     CrossRef
S100B Levels in Patients with Type 2 Diabetes Mellitus and Co-Occurring Depressive Symptoms
Panagiota Katsanou, Nikolaos Tentolouris, Despoina Perrea, Spyridon Katsanos, Vasiliki Ntova, Virginia Antrian, Panagiotis Konstantopoulos, Antonios Politis
Depression Research and Treatment.2018; 2018: 1.     CrossRef
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
Oliver Ambrée, Veerle Bergink, Laura Grosse, Judith Alferink, Hemmo A. Drexhage, Matthias Rothermundt, Volker Arolt, Tom K. Birkenhäger
International Journal of Neuropsychopharmacology.2016; 19(3): pyv103.     CrossRef
Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder
Meng-Chang Tsai, Tiao-Lai Huang
Psychiatry Research.2016; 235: 38.     CrossRef
Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder
Frank Martin Schmidt, Roland Mergl, Barbara Stach, Ina Jahn, Peter Schönknecht
The World Journal of Biological Psychiatry.2015; 16(2): 106.     CrossRef
Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers
Bhautesh D. Jani, Gary McLean, Barbara I. Nicholl, Sarah J. E. Barry, Naveed Sattar, Frances S. Mair, Jonathan Cavanagh
Frontiers in Human Neuroscience.2015;[Epub]     CrossRef
Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein, and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested within a Randomized, Controlled Trial
Daniel M. Pearlman, Jeremiah R. Brown, Todd A. MacKenzie, Felix Hernandez, Souhel Najjar, Malú G. Tansey
PLoS ONE.2014; 9(10): e111110.     CrossRef
S100B overexpression increases behavioral and neural plasticity in response to the social environment during adolescence
Jens Buschert, Christa Hohoff, Chadi Touma, Rupert Palme, Matthias Rothermundt, Volker Arolt, Weiqi Zhang, Oliver Ambrée
Journal of Psychiatric Research.2013; 47(11): 1791.     CrossRef
Neurobiology of Major Depressive Disorder
Rosa Villanueva
Neural Plasticity.2013; 2013: 1.     CrossRef
Blood–brain barrier dysfunction in brain diseases: Clinical experience
Karl Schoknecht, Hadar Shalev
Epilepsia.2012; 53(s6): 7.     CrossRef
Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease
Jwa-Kyung Kim, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song
Clinical Biochemistry.2012; 45(18): 1573.     CrossRef